Erman Salih Istifli
Dr. Erman Salih Istifli’s postdoctoral studies include the discovery of candidate phytochemicals in the treatment of SARS-CoV-2, DNA–ligand interactions, and the discovery of plant-based natural inhibitors against certain enzymes (AChE, BChE, alpha-amylase, alpha-glucosidase, and tyrosinase) that are important regulators of human health. He has been the scientific editor of the International Journal of Plant Based Pharmaceuticals since 2021.